- About Us
- Clinical Trials
- News & Publications
- Business Development
SOTIO opens office in Basel, Switzerland, to accelerate development of its pipeline products
SOTIO, a biotechnology company owned by the PPF Group, announce today the opening of offices of SOTIO Biotech AG at the Technology Park Basel, Switzerland. The SOTIO office will host the clinical development team, as well as other functions to progress its broad clinical development pipeline towards filing for marketing authorization and commercial launch.